Understanding KCNA2 Epilepsy with Researcher Dr. Ulrike (Uli') Hedrich-Klimosch & Dr. Nancy Musarra

What does a KCNA2 diagnosis actually mean, and how do researchers study rare epilepsies? In this episode of the KCNA2 & Rare Epilepsy Podcast, Nancy speaks with Dr. Ulrike (Uli') Hedrich-Klimosch, a researcher in Germany focused on epilepsy, ion channels, neuronal networks, and KCNA2-related disease. Together, they break down complex ideas in a way families can understand, including what a channelopathy is, how gain-of-function and loss-of-function variants differ, why treatments like 4-aminopyridine (4-AP) may help some patients, and how research moves from the lab to the clinic. This conversation is especially helpful for: ➜ parents and caregivers navigating a new diagnosis ➜ families trying to better understand KCNA2 ➜ clinicians and researchers interested in patient-centered explanations ➜ anyone wanting clearer language around rare epilepsy research The episode also touches on the real-life impact of rare epilepsy on families, the promise and limits of current treatments, and why rare disease research matters so deeply. Learn more about KCNA2 epilepsy, definitions, and family resources at the KCNA2 website: https://www.kcna2epilepsy.org/ You can also explore the KCNA2 glossary on the website for simple explanations of terms used in this episode.